Novel Drug Developments to Drive Tumor Necrosis Factor (TNF) Inhibitors Market to a Valuation of US$ 45.5 Bn by 2027: Fact.MR Study
May 04, 2022 09:45 ET
|
FACT.MR
United States, Rockville, MD, May 04, 2022 (GLOBE NEWSWIRE) -- As per industry analysis on tumor necrosis factor (TNF) inhibitors by Fact.MR, a market research and competitive intelligence provider,...